Europe — EMA
Ovreena (Ethinylestradiol, Levonorgestrel)
Ethinylestradiol, the active ingredient in Ovreena, is a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy in women of reproductive age.
Request sourcing
What is Ethinylestradiol, Levonorgestrel?
Ethinylestradiol, the active ingredient in Ovreena, is a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy in women of reproductive age. GNH USA supplies Ovreena as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Ovreena as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Ethinylestradiol, Levonorgestrel used for?
Ovreena is a combined oral contraceptive that acts on the hormonal regulation of the menstrual cycle.
- Contraception: Provides reliable prevention of pregnancy when taken as directed. - Menstrual cycle regulation: Helps to create more predictable menstrual bleeding patterns. - Acne management: Reduces acne severity associated with hormonal fluctuations. - Endometriosis symptom relief: Alleviates pain and reduces lesion progression. - Menstrual‑associated migraine migraine: Improves migraine frequency related to menstrual cycle.
What are the side effects of Ethinylestradiol, Levonorgestrel?
Side effects may occur .
Common ": - ... ... ...
What precautions apply to Ethinylestradiol, Levonorgestrel?
...
